<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0001915'>Aplastic anemia</z:hpo> is a condition in which the bone marrow fails to produce adequate numbers of peripheral blood elements </plain></SENT>
<SENT sid="1" pm="."><plain>The incidences of <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> and <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> in patients with congenital <z:e sem="disease" ids="C0005779" disease_type="Disease or Syndrome" abbrv="">coagulation disorders</z:e> and <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> are very low </plain></SENT>
<SENT sid="2" pm="."><plain>In this paper, a case of late stent <z:mp ids='MP_0005048'>thrombosis</z:mp> within a drug-eluting stent occurring after platelet transfusion in a patient with <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> is presented </plain></SENT>
<SENT sid="3" pm="."><plain>The authors' observations emphasize the risks of platelet transfusion and the authors' support withholding such a treatment unless vitally indicated, in patients with coronary artery stent implantation and even in those on dual antiplatelet therapy </plain></SENT>
</text></document>